OvaScience to Present at the 36th Annual J.P. Morgan Healthcare Conference
January 04 2018 - 7:00AM
Business Wire
OvaScience℠ (NASDAQ: OVAS), a company focused on the discovery,
development and commercialization of new treatment options for
women and families struggling with infertility, today announced
that Christopher Kroeger, M.D., Chief Executive Officer of
OvaScience, will present a corporate overview at the 36th Annual
J.P. Morgan Healthcare Conference on Thursday, January 11, 2018 at
11:00 a.m. PT (2:00 p.m. ET) at the Westin St. Francis Hotel in San
Francisco, California.
A live audio webcast of the presentation can be accessed by
visiting the investor section of the company’s website at
www.ovascience.com. A replay of the webcast will be archived on the
OvaScience website for 30 days following the presentation.
About OvaScience℠OvaScience℠, Inc. (NASDAQ:OVAS) is a
company focused on the discovery, development and commercialization
of new treatment options for women and families struggling with
infertility. Each OvaScience treatment is based on the
Company’s proprietary technology platform that leverages the
breakthrough discovery of egg precursor (EggPC℠) cells – immature
egg cells found inside the protective ovarian lining. OvaScience is
developing OvaPrime℠, which could increase a woman’s egg reserve
and OvaTure℠, a potential in vitro fertilization (IVF) treatment
that could help a woman produce new, fertilizable eggs without
hormone injections. OvaScience’s AUGMENT℠ treatment, a fertility
option designed to improve IVF success rates, is available in
certain IVF clinics in Canada and Japan. OvaScience treatments are
not available in the U.S. For more information, visit
www.ovascience.com.
###
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180104005233/en/
OvaScience, Inc.Jennifer Viera,
617-420-8748jviera@ovascience.com
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Sep 2023 to Sep 2024